Pharmacometric Analysis of Intranasal and Intravenous Nalbuphine to Optimize Pain Management in Infants

Overview of attention for article published in Frontiers in Pediatrics, March 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

A randomized, double‐blind study to compare the efficacy and safety of nalbuphine nasal spray and injectable solution in patients after orthopaedic interventions and traumatological procedures

Article in British Journal of Clinical Pharmacology (April 2024)

Pharmacometric in silico studies used to facilitate a national dose standardisation process in neonatology - application to amikacin.

Article in Swiss Medical Weekly (April 2024)

Impact of intravenous administration of nalbuphine at different time points for postoperative analgesia and sedation in adenotonsillectomized children: a prospective, randomized controlled trial

Article in World Journal of Pediatric Surgery (October 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.